Osteoradionecrosis After Intensity-Modulated Radiation Therapy or Proton Therapy in Oropharyngeal Carcinoma.
Yang F, Dee EC, Singh A, Wu Y, Suggitt JO, Treechairusame T, Silverio Polanco E, Honawar A, Zhang Z, Mah D, Sine K, Shim A, Lin H, Kang JJ, Tsai CJ, McBride SM, Riaz N, Gelblum DY, Zakeri K, Chen L, Shamseddine A, Yu Y, Huryn JM, Yom SK, Cracchiolo J, Ganly I, Cohen MA, Sherman EJ, Ho AL, Wong RJ, Estilo CL, Lee NY.
Yang F, et al.
JAMA Otolaryngol Head Neck Surg. 2026 Feb 1;152(2):135-143. doi: 10.1001/jamaoto.2025.4179.
JAMA Otolaryngol Head Neck Surg. 2026.
PMID: 41296362
While proton therapy offers superior dose conformality, its impact on ORN risk remains uncertain, particularly in patients with oropharyngeal squamous cell carcinoma (OPSCC). ...ORN rates were significantly higher after proton therapy compared w …
While proton therapy offers superior dose conformality, its impact on ORN risk remains uncertain, particularly in patients wit …